Yosuke Kayama Selected Research

Yosuke Kayama Research Topics

Disease

8	Type 2 Diabetes Mellitus (MODY) 01/2019 - 10/2012
6	Heart Failure 02/2015 - 07/2009
4	Inflammation (Inflammations) 02/2015 - 07/2009
3	Abdominal Aortic Aneurysm 01/2018 - 01/2016
3	Heart Diseases (Heart Disease) 08/2014 - 12/2013
3	Ischemia 08/2014 - 12/2013
3	Hypertrophy 06/2014 - 12/2006
2	Dyslipidemias (Dyslipidemia) 11/2018 - 01/2018
2	Hypertension (High Blood Pressure) 11/2018 - 01/2018
2	Fibrosis (Cirrhosis) 08/2015 - 02/2015
2	Atherosclerosis 02/2015 - 05/2013
2	Cardiomegaly (Heart Hypertrophy) 06/2014 - 12/2006
1	Chronic Renal Insufficiency 11/2018
1	Atrial Fibrillation 11/2018
1	Obesity 11/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2018
1	Left Ventricular Dysfunction 11/2018
1	Body Weight (Weight, Body) 01/2017
1	Hyperphagia (Overeating) 01/2017
1	Hyperglycemia 10/2015
1	Diabetes Mellitus 08/2015
1	Aneurysm (Aneurysms) 05/2015
1	Diabetic Cardiomyopathies 02/2015
1	Reperfusion Injury 08/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2014
1	Cardiac Tamponade 07/2013
1	Insulin Resistance 05/2013
1	Arteriosclerosis 10/2012
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 08/2010

Drug/Important Bio-Agent (IBA)

2	Blood Glucose (Blood Sugar)IBA 11/2018 - 01/2017
2	Transcription Factors (Transcription Factor)IBA 08/2015 - 12/2006
2	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 02/2015 - 07/2009
2	SodiumIBA 06/2014 - 12/2013
2	Proteins (Proteins, Gene)FDA Link 06/2014 - 07/2009
2	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2013 - 01/2012
2	Oxidants (Oxidizing Agents)IBA 05/2013 - 10/2012
2	Angiotensin Receptor AntagonistsIBA 05/2013 - 10/2012
2	candesartanIBA 05/2013 - 10/2012
1	CholesterolIBA 01/2019
1	Nicotine FDA Link 01/2018
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	CanagliflozinIBA 01/2018
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2017
1	ipragliflozinIBA 01/2017
1	SaltsIBA 01/2016
1	Antihypertensive Agents (Antihypertensives)IBA 01/2016
1	Heme Oxygenase-1IBA 01/2016
1	AntioxidantsIBA 10/2015
1	alpha2 Subunit Collagen Type IIBA 08/2015
1	Pancreatic Elastase (Elastase)IBA 05/2015
1	ElementsIBA 05/2015
1	Acetylcysteine (Siran)FDA LinkGeneric 02/2015
1	Creatine Kinase (Creatine Phosphokinase)IBA 08/2014
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 08/2014
1	AldosteroneIBA 08/2014
1	GlucocorticoidsIBA 06/2014
1	Dexamethasone (Maxidex)FDA LinkGeneric 06/2014
1	Messenger RNA (mRNA)IBA 06/2014
1	Hormones (Hormone)IBA 06/2014
1	Pioglitazone (Actos)FDA Link 05/2013
1	AdiponectinIBA 05/2013
1	Plasminogen Activators (Plasminogen Activator)IBA 05/2013
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 05/2013
1	C-Reactive ProteinIBA 05/2013
1	Phosphotransferases (Kinase)IBA 08/2010
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 08/2010
1	DNA (Deoxyribonucleic Acid)IBA 12/2006
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2006
1	Heat Shock Transcription FactorsIBA 12/2006

Therapy/Procedure

2	Therapeutics 11/2018 - 08/2015